P04.15.B SEMI-AUTOMATIC INTERACTIVE RESPONSE ASSESSMENT FOR GLIOMAS WITH RANO2.0-ASSIST

Abstract BACKGROUND Recently, Response Assessment in Neuro-Oncology (RANO) criteria for high- and low-grade gliomas in adults were revised (RANO 2.0). Measurements can be time-consuming and subjective, resulting in increased inter-rater variability and reduced reproducibility. Automatic methods have been introduced in the past, however, existing tools are not based on the updated criteria, not freely available, and do not allow for interactive correction and validation of automatic results. To address these shortcomings, we developed a new tool called RANO2.0-assist (an extension of the research software 3D Slicer). RANO2.0-assist allows the user to modify, add, and remove bi-dimensional measurements, specify measurable and non-measurable lesions, and provide additional clinical information. Here, we evaluate automatic two-dimensional measurements provided by RANO2.0-assist as well as the response assessment classification by comparison with a manual ground-truth. MATERIALS AND METHODS A glioma dataset of 19 baseline MRI sessions with follow-ups was evaluated with RANO2.0-assist. Each session included contrast-enhanced T1-weighted, native T1-weighted, FLAIR, and T2-weighted scans. Manual two-dimensional measurements were provided by two expert radiologists, classifying the sessions into progressive disease (PD, n=13), stable disease (SD, n=6), partial response (PR, n=0), and complete response (CR, n=0). The RANO2.0-assist pipeline consists of: 1) image registration to a reference space 2) automatic segmentation of enhancing tumour tissue, oedematous tissue, necrotic tissue, and resection cavity 3) matching of lesions between baseline and follow-up 4) automatic measurement of bi-dimensional products and response classification according to RANO2.0 criteria. RESULTS On average, bi-dimensional measurements obtained with RANO2.0-assist were larger than manual measurements with an average relative difference of 21% ± 36%. This is because automatic bi-dimensional measurements capture narrow extensions of enhancing tissue that tend to be ignored in the manual ground-truth. However, this bias is partially canceled out in the computation of the response classification: Assuming the reference standard was correct, 15 cases (79%) were correctly classified without any alteration of the automated bi-demensional measurements, while 4 required alteration. CONCLUSION Our experiments show the potential for automatic response assessment but also highlight its pitfalls and need for human validation and correction of edge cases (human-in-the-loop). RANO2.0-assist provides an interactive user interface to facilitate this process. In the future, we aim to evaluate the impact on treatment response assessment through various options provided by RANO2.0-assist, such as post-processing of the automatic segmentations with morphological opening/closing operations.

Authors

Institutions

Publication Details

Journal
Neuro-Oncology
Published
2025-10-01
DOI
https://doi.org/10.1093/neuonc/noaf193.201
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

P04.15.B SEMI-AUTOMATIC INTERACTIVE RESPONSE ASSESSMENT FOR GLIOMAS WITH RANO2.0-ASSIST

Thomas C. Booth, Tom Vercauteren, Aaron Kujawa, T Shi
Neuro-Oncology
Glioma Diagnosis and Treatment
article

P04.15.B SEMI-AUTOMATIC INTERACTIVE RESPONSE ASSESSMENT FOR GLIOMAS WITH RANO2.0-ASSIST

Thomas C. Booth, Tom Vercauteren, Aaron Kujawa, T Shi
article en

Abstract

Abstract BACKGROUND Recently, Response Assessment in Neuro-Oncology (RANO) criteria for high- and low-grade gliomas in adults were revised (RANO 2.0). Measurements can be time-consuming and subjective, resulting in increased inter-rater variability and reduced reproducibility. Automatic methods have been introduced in the past, however, existing tools are not based on the updated criteria, not freely available, and do not allow for interactive correction and validation of automatic results. To address these shortcomings, we developed a new tool called RANO2.0-assist (an extension of the research software 3D Slicer). RANO2.0-assist allows the user to modify, add, and remove bi-dimensional measurements, specify measurable and non-measurable lesions, and provide additional clinical information. Here, we evaluate automatic two-dimensional measurements provided by RANO2.0-assist as well as the response assessment classification by comparison with a manual ground-truth. MATERIALS AND METHODS A glioma dataset of 19 baseline MRI sessions with follow-ups was evaluated with RANO2.0-assist. Each session included contrast-enhanced T1-weighted, native T1-weighted, FLAIR, and T2-weighted scans. Manual two-dimensional measurements were provided by two expert radiologists, classifying the sessions into progressive disease (PD, n=13), stable disease (SD, n=6), partial response (PR, n=0), and complete response (CR, n=0). The RANO2.0-assist pipeline consists of: 1) image registration to a reference space 2) automatic segmentation of enhancing tumour tissue, oedematous tissue, necrotic tissue, and resection cavity 3) matching of lesions between baseline and follow-up 4) automatic measurement of bi-dimensional products and response classification according to RANO2.0 criteria. RESULTS On average, bi-dimensional measurements obtained with RANO2.0-assist were larger than manual measurements with an average relative difference of 21% ± 36%. This is because automatic bi-dimensional measurements capture narrow extensions of enhancing tissue that tend to be ignored in the manual ground-truth. However, this bias is partially canceled out in the computation of the response classification: Assuming the reference standard was correct, 15 cases (79%) were correctly classified without any alteration of the automated bi-demensional measurements, while 4 required alteration. CONCLUSION Our experiments show the potential for automatic response assessment but also highlight its pitfalls and need for human validation and correction of edge cases (human-in-the-loop). RANO2.0-assist provides an interactive user interface to facilitate this process. In the future, we aim to evaluate the impact on treatment response assessment through various options provided by RANO2.0-assist, such as post-processing of the automatic segmentations with morphological opening/closing operations.

Neuro-OncologyVol. 27(Supplement_3)
King's College London (GB)
Openalex Percentile: Top 62%
Glioma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.